Related Experiment Videos
Interactions between H1-antagonists and opioids: a drug discrimination study
1Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan. suzuki@hoshi.ac.jp
Psychopharmacology
|June 1, 1997
Summary
Combining opioids like pentazocine with H1-antagonists such as tripelennamine can enhance drug-seeking behaviors. Opioids potentiated the cocaine-like effects of H1-antagonists, suggesting a role in increased rewarding effects.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Opioid and histamine H1-receptor antagonist combinations can enhance rewarding effects.
- Discriminative stimulus effects are believed to relate to drug rewarding properties.
Purpose of the Study:
- To examine the effects of combined opioid and H1-antagonist treatment on discriminative stimulus effects in rats.
- To investigate the relationship between drug combinations, discriminative stimuli, and rewarding effects.
Main Methods:
- Rats were trained to discriminate between cocaine or morphine and saline.
- The effects of opioids (pentazocine, dihydrocodeine) and H1-antagonists (tripelennamine, chlorpheniramine) alone and in combination were assessed.
- Generalization and potentiation of drug-specific discriminative stimulus effects were analyzed.
Main Results:
- H1-antagonists, but not opioids, generalized to cocaine's discriminative effects.
- Opioids potentiated the cocaine-like discriminative effects of H1-antagonists.
- Opioids, but not H1-antagonists, generalized to morphine's discriminative effects.
- H1-antagonists did not affect the morphine-like discriminative effects of opioids.
Conclusions:
- Opioid potentiation of H1-antagonist's cocaine-like discriminative effects may contribute to enhanced rewarding effects of these combinations.
- Findings suggest a specific interaction between opioids and H1-antagonists influencing drug reward pathways.